These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 16863557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
    Jorgensen R, Angulo P, Dickson ER, Lindor KD.
    Am J Gastroenterol; 2002 Oct; 97(10):2647-50. PubMed ID: 12385454
    [Abstract] [Full Text] [Related]

  • 5. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ, Stone J, Cauch-Dudek K, Poupon R, Chazouilleres O, Lindor KD, Petz J, Dickson ER, Poupon RE.
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [Abstract] [Full Text] [Related]

  • 6. [Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope].
    Olsson R.
    Lakartidningen; 2002 Mar 21; 99(12):1325-30. PubMed ID: 11998165
    [Abstract] [Full Text] [Related]

  • 7. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP, Jorgensen RA, Dickson ER, Lindor KD.
    Am J Gastroenterol; 1996 Nov 21; 91(11):2314-7. PubMed ID: 8931409
    [Abstract] [Full Text] [Related]

  • 8. Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial.
    Papatheodoridis GV, Hadziyannis ES, Deutsch M, Hadziyannis SJ.
    Am J Gastroenterol; 2002 Aug 21; 97(8):2063-70. PubMed ID: 12190178
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM, Schrumpf E.
    Tidsskr Nor Laegeforen; 1997 Sep 30; 117(23):3370-3. PubMed ID: 9411890
    [Abstract] [Full Text] [Related]

  • 10. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW, Gunsar F, Feudjo M, Rigamonti C, Vlachogiannakos J, Carpenter JR, Burroughs AK.
    Aliment Pharmacol Ther; 2005 Feb 01; 21(3):217-26. PubMed ID: 15691295
    [Abstract] [Full Text] [Related]

  • 11. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
    ter Borg PC, Schalm SW, Hansen BE, van Buuren HR, Dutch PBC Study Group.
    Am J Gastroenterol; 2006 Sep 01; 101(9):2044-50. PubMed ID: 16848809
    [Abstract] [Full Text] [Related]

  • 12. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
    Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R.
    Hepatology; 2000 Dec 01; 32(6):1196-9. PubMed ID: 11093724
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.
    Bonnand AM, Heathcote EJ, Lindor KD, Poupon RE.
    Hepatology; 1999 Jan 01; 29(1):39-43. PubMed ID: 9862847
    [Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V, Michael S, Prego V.
    Am J Gastroenterol; 1994 Mar 01; 89(3):392-8. PubMed ID: 8122652
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES.
    Hepatology; 1996 Nov 01; 24(5):1098-103. PubMed ID: 8903382
    [Abstract] [Full Text] [Related]

  • 16. Natural history of pruritus in primary biliary cirrhosis.
    Talwalkar JA, Souto E, Jorgensen RA, Lindor KD.
    Clin Gastroenterol Hepatol; 2003 Jul 01; 1(4):297-302. PubMed ID: 15017671
    [Abstract] [Full Text] [Related]

  • 17. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
    Angulo P, Jorgensen RA, Lindor KD.
    Am J Gastroenterol; 2001 Nov 01; 96(11):3152-7. PubMed ID: 11721764
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
    Kaplan MM, Cheng S, Price LL, Bonis PA.
    Hepatology; 2004 Apr 01; 39(4):915-23. PubMed ID: 15057894
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis.
    Leuschner U, Manns MP, Eisebitt R.
    Z Gastroenterol; 2005 Sep 01; 43(9):1051-9. PubMed ID: 16142614
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA, Sanai FM, Swain MG.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):813-20. PubMed ID: 16918885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.